DrugPatentWatch Database Preview
TERIL Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Teril, and what generic alternatives are available?
The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.
Summary for TERIL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 110 |
| Patent Applications: | 4,546 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TERIL at DailyMed |
Pharmacology for TERIL
Medical Subject Heading (MeSH) Categories for TERIL
Synonyms for TERIL
| 11-benzo[b][1]benzazepinecarboxamide |
| 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide |
| 2-azatricyclo[9.4.0.0;{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide |
| 2-AZATRICYCLO[9.4.0.0(3),?]PENTADECA-1(11),3(8),4,6,9,12,14-HEPTAENE-2-CARBOXAMIDE |
| 298-46-4 |
| 33CM23913M |
| 5-Carbamoyl-5H-dibenz(b,f)azepine |
| 5-Carbamoyl-5H-dibenz[b,f]azepine |
| 5-Carbamoyl-5H-dibenzo(b,f)azepine |
| 5-Carbamoyldibenzo(b,f)azepine |
| 5-Carbamyl-5H-dibenzo(b,f)azepine |
| 5-Carbamyldibenzo(b,f)azepine |
| 5-Carbomoyl-5H-dibenzo(b,f)azepine |
| 5H-Dibenz(b,f)azepine-5-carboxamide |
| 5H-Dibenz[ b, f]azepine-5-carboxamide |
| 5H-Dibenz[b,f]azepine-5- carboxamide |
| 5H-Dibenz[b,f]azepine-5-carboxamide |
| 5H-Dibenz[b,f]azepine-5-carboxamine |
| 5H-Dibenzo[b,f]azepine-5-carboxamide |
| 5H-Dibenzo[b,f]azepine-5-carboxamide # |
| 5H-dibenzo[b,f]azepine-5-carboximidic acid |
| 85756-57-6 (di-hydrate) |
| A820074 |
| AB00051931_19 |
| AB00051931_20 |
| AB00051931-17 |
| AB00051931-18 |
| AB0070254 |
| AB1009530 |
| AC-9538 |
| AC1L1DXT |
| AC1Q4ZSU |
| AC1Q4ZSV |
| ACT02606 |
| AJ-08227 |
| AJ-08230 |
| AK116064 |
| AKOS003235644 |
| AKOS025397243 |
| Amizepin |
| Amizepine |
| AN-6325 |
| AOB5783 |
| Apo-Carbamazepine |
| Atretol |
| Azapentacene; Sodium 5,12-dihydroazapentacene disulfonate; 5,12-Dihydroquinoxalino[2,3-b]phenazine sulfonate sodium salt |
| BBL005372 |
| BC200975 |
| BDBM50003659 |
| benzo[b][1]benzazepine-11-carboxamide |
| BG0497 |
| BIDD:GT0479 |
| BIM-0050280.0001 |
| Bio-0751 |
| Bipotrol |
| Biston |
| BPBio1_000225 |
| BRD-K71799949-001-06-7 |
| BRN 1246090 |
| BSPBio_000203 |
| BSPBio_001929 |
| C 4024 |
| C-13993 |
| C06868 |
| Calepsin |
| Carbamazepan |
| Carbamazepen |
| Carbamazepin |
| Carbamazepina |
| Carbamazepina [INN-Spanish] |
| carbamazepine |
| Carbamazepine (Carbatrol) |
| Carbamazepine (iv, epilepsy) |
| Carbamazepine (iv, epilepsy), Lundbeck |
| Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals |
| Carbamazepine (JP17/USP/INN) |
| carbamazepine (Tegretol) |
| Carbamazepine [USAN:INN:BAN:JAN] |
| Carbamazepine [USAN:USP:INN:BAN:JAN] |
| Carbamazepine 1.0 mg/ml in Methanol |
| Carbamazepine Anhydrous |
| carbamazepine hydrate |
| Carbamazepine Hydrochloride |
| Carbamazepine Phosphate |
| Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
| carbamazepine sulfate |
| carbamazepine tartrate |
| Carbamazepine, analytical standard |
| Carbamazepine, British Pharmacopoeia (BP) Reference Standard |
| Carbamazepine, European Pharmacopoeia (EP) Reference Standard |
| Carbamazepine, meets USP testing specifications |
| Carbamazepine, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Carbamazepine, powder |
| CARBAMAZEPINE, U.S.P. |
| Carbamazepine, United States Pharmacopeia (USP) Reference Standard |
| Carbamazepinum |
| Carbamazepinum [INN-Latin] |
| Carbamezepine |
| Carbatrol |
| Carbatrol extended-release |
| Carbazepin |
| Carbazepine |
| Carbelan |
| Carnexiv |
| CAS-298-46-4 |
| CBChromo1_000350 |
| CC-25382 |
| CC-25383 |
| CCG-38931 |
| CDS1_002710 |
| CHEBI:3387 |
| CHEMBL108 |
| ChemDiv1_018966 |
| CPD001227191 |
| CS-2225 |
| D00252 |
| D04MSM |
| DB00564 |
| dibenz[b,f]azepine-5-carboxamide |
| dibenzo[b,f]azepine-5-carboxamide |
| Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine) |
| DivK1c_000388 |
| DivK1c_003750 |
| DR000542 |
| DSSTox_CID_2731 |
| DSSTox_GSID_22731 |
| DSSTox_RID_76704 |
| DTXSID4022731 |
| EINECS 206-062-7 |
| EN300-21678 |
| Epitol |
| Epitope ID:174842 |
| Equetro |
| Equetro (TN) |
| EU-0100292 |
| F0348-2551 |
| FFGPTBGBLSHEPO-UHFFFAOYSA-N |
| Finlepsin |
| FT-0602927 |
| FT-0696814 |
| G 32883 |
| G-32883 |
| Geigy 32883 |
| GP8250 |
| GTPL5339 |
| H2605 |
| H495 |
| HMS1568K05 |
| HMS1920I17 |
| HMS2090M07 |
| HMS2091O19 |
| HMS2095K05 |
| HMS2233G16 |
| HMS3039K09 |
| HMS3259B21 |
| HMS3260L06 |
| HMS3372J13 |
| HMS3657G03 |
| HMS501D10 |
| HMS640O02 |
| HSDB 3019 |
| HY-B0246 |
| I06-0863 |
| IDI1_000388 |
| IMED104589831 |
| Iminostilbene-N-carboxamide |
| Karbamazepin |
| KB-246109 |
| KBio1_000388 |
| KBio2_000516 |
| KBio2_003084 |
| KBio2_005652 |
| KBio3_001149 |
| KBioGR_000724 |
| KBioSS_000516 |
| KS-00000KI8 |
| KS-5146 |
| Lexin |
| Lopac-C-4024 |
| Lopac0_000292 |
| LP00292 |
| LS-60362 |
| MCULE-9121567287 |
| MFCD00005073 |
| MLS000069652 |
| MLS001055475 |
| MLS001074172 |
| MLS002548877 |
| MolPort-000-710-574 |
| MolPort-023-220-275 |
| NC00679 |
| NCGC00015234-01 |
| NCGC00015234-02 |
| NCGC00015234-03 |
| NCGC00015234-04 |
| NCGC00015234-05 |
| NCGC00015234-06 |
| NCGC00015234-07 |
| NCGC00015234-08 |
| NCGC00015234-09 |
| NCGC00015234-10 |
| NCGC00015234-11 |
| NCGC00015234-12 |
| NCGC00015234-13 |
| NCGC00015234-14 |
| NCGC00015234-15 |
| NCGC00015234-16 |
| NCGC00015234-19 |
| NCGC00023877-03 |
| NCGC00023877-04 |
| NCGC00023877-05 |
| NCGC00023877-06 |
| NCGC00023877-07 |
| NCGC00023877-08 |
| NCGC00253982-01 |
| NCGC00259822-01 |
| NCGC00260977-01 |
| Neurotol |
| Neurotop retard |
| NINDS_000388 |
| Novo-Carbamaz |
| NSC 169864 |
| NSC-169864 |
| NSC-755920 |
| NSC169864 |
| NSC755920 |
| Nu-Carbamazepine |
| Opera_ID_72 |
| Oprea1_790775 |
| Pharmakon1600-01500159 |
| PL053430 |
| Prestwick_104 |
| Prestwick0_000052 |
| Prestwick1_000052 |
| Prestwick2_000052 |
| Prestwick3_000052 |
| Q-200792 |
| s1693 |
| SAM002264603 |
| SBI-0050280.P004 |
| SC-16243 |
| SCHEMBL21639 |
| Sirtal |
| SMR000058201 |
| SMR001227191 |
| SPBio_000170 |
| SPBio_002124 |
| SPD-417 |
| Spectrum_000096 |
| SPECTRUM1500159 |
| Spectrum2_000125 |
| Spectrum3_000325 |
| Spectrum4_000262 |
| Spectrum5_000936 |
| SR-01000000229 |
| SR-01000000229-2 |
| ST075773 |
| ST2418853 |
| Stazepin |
| Stazepine |
| STK177357 |
| STL453548 |
| Taro-Carbamazepine |
| Taro-Carbamazepine Cr |
| Tegretal |
| Tegretol |
| Tegretol (TN) |
| Tegretol Chewtabs |
| Tegretol Cr |
| Tegretol-Xr |
| Telesmin |
| Timonil |
| Tox21_110104 |
| Tox21_110104_1 |
| Tox21_202273 |
| Tox21_300195 |
| Tox21_500292 |
| Trimonil |
| UNII-33CM23913M |
| WLN: T C676 BNJ BVZ |
| Z2199879032 |
| ZB000594 |
| ZINC4785 |
US Patents and Regulatory Information for TERIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm | TERIL | carbamazepine | SUSPENSION;ORAL | 076729-001 | Sep 20, 2004 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Taro | TERIL | carbamazepine | TABLET;ORAL | 076525-001 | Sep 26, 2003 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
